These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 2877399

  • 1. The effect of the dopamine agonist pergolide on tyrosine hydroxylase activity in rat striatal and limbic miniprisms in vitro: a model for the dopamine autoreceptor?
    Vulto AG, Fowler CJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):349-53. PubMed ID: 2877399
    [Abstract] [Full Text] [Related]

  • 2. Is inhibition of striatal synaptosomal tyrosine hydroxylation by dopamine agonists a measure of dopamine autoreceptor function?
    Fowler CJ, Thorell G, Andersson M, Magnusson O.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):12-9. PubMed ID: 2866447
    [Abstract] [Full Text] [Related]

  • 3. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 4. Adenosine A2 stimulation of tyrosine hydroxylase in rat striatal minces is reversed by dopamine D2 autoreceptor activation.
    Booth RG, Baldessarini RJ.
    Eur J Pharmacol; 1990 Aug 28; 185(2-3):217-21. PubMed ID: 1979274
    [Abstract] [Full Text] [Related]

  • 5. Actions of (+/-)-7-hydroxy-N,N-dipropylaminotetralin (7-OH-DPAT) on dopamine synthesis in limbic and extrapyramidal regions of rat brain.
    Booth RG, Baldessarini RJ, Marsh E, Owens CE.
    Brain Res; 1994 Oct 31; 662(1-2):283-8. PubMed ID: 7859086
    [Abstract] [Full Text] [Related]

  • 6. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.
    Ahlenius S, Hillegaart V, Wijkström A.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May 31; 339(5):551-6. PubMed ID: 2570361
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Chronic cocaine treatment does not alter rat striatal D2 autoreceptor sensitivity to pergolide.
    Fitzgerald JL, Reid JJ.
    Brain Res; 1991 Feb 15; 541(2):327-33. PubMed ID: 1829016
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E, Nahorski SR.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May 15; 335(5):508-12. PubMed ID: 2441268
    [Abstract] [Full Text] [Related]

  • 11. Destruction of post-synaptic dopamine receptors prevents neuroleptic-induced activation of striatal tyrosine hydroxylase but not dopamine synthesis stimulation.
    Di Chiara G, Onali PL, Tissari AH, Porceddu ML, Morelli M, Gessa GL.
    Life Sci; 1978 Aug 21; 23(7):691-6. PubMed ID: 29204
    [No Abstract] [Full Text] [Related]

  • 12. Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.
    Stamford JA, Kruk ZL, Millar J.
    Br J Pharmacol; 1991 Jan 21; 102(1):45-50. PubMed ID: 1675147
    [Abstract] [Full Text] [Related]

  • 13. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
    Strait KA, Kuczenski R.
    Mol Pharmacol; 1986 Jun 21; 29(6):561-9. PubMed ID: 2872588
    [Abstract] [Full Text] [Related]

  • 14. Dopamine autoreceptors modulate the phosphorylation of tyrosine hydroxylase in rat striatal slices.
    Salah RS, Kuhn DM, Galloway MP.
    J Neurochem; 1989 May 21; 52(5):1517-22. PubMed ID: 2565375
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
    Magnusson O, Fowler CJ, Mohringe B, Wijkström A, Ogren SO.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr 21; 337(4):379-84. PubMed ID: 2900472
    [Abstract] [Full Text] [Related]

  • 16. Dopamine receptor mediated inhibition by pergolide of electrically-evoked 3H-dopamine release from striatal slices of cat and rat: slight effect of ascorbate.
    Lehmann J, Arbilla S, Langer SZ.
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Aug 21; 317(1):31-5. PubMed ID: 7279007
    [Abstract] [Full Text] [Related]

  • 17. The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.
    Reid MS, O'Connor WT, Herrera-Marschitz M, Ungerstedt U.
    Brain Res; 1990 Jun 11; 519(1-2):255-60. PubMed ID: 1975763
    [Abstract] [Full Text] [Related]

  • 18. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.
    Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R, Neumeyer JL.
    Mol Pharmacol; 1990 Jul 11; 38(1):92-101. PubMed ID: 1973525
    [Abstract] [Full Text] [Related]

  • 19. Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats.
    Scalzo FM, Spear LP.
    Psychopharmacology (Berl); 1985 Jul 11; 85(3):271-6. PubMed ID: 3923514
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.